Heterogeneity of patients with latent autoimmune diabetes in adults: Linkage to autoimmunity is apparent only in those with perceived need for insulin treatment results from the nord-trondelag health (HUNT) study

Diabetes Care

Volumn 32, Issue 2, 2009, Pages 245-250

  Radtke, Maria A ^a   Midthjell, Kristian ^b   Nilsen, Tom I Lund ^b   Grill, Valdemar ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN; ANTIDIABETIC AGENT; AUTOANTIBODY; GLUTAMATE DECARBOXYLASE;

ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BODY MASS; CORRELATION ANALYSIS; GENETIC HETEROGENEITY; GLUCOSE BLOOD LEVEL; IMPAIRED GLUCOSE TOLERANCE; INSULIN TREATMENT; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PHENOTYPE; PREVALENCE; PROTEIN BLOOD LEVEL; ADULT; AGED; BLOOD; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MIDDLE AGED; NORWAY; PERCEPTION; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE;

ADULT; AGED; AUTOANTIBODIES; AUTOIMMUNITY; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GLUTAMATE DECARBOXYLASE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; METABOLIC SYNDROME X; MIDDLE AGED; NORWAY; PERCEPTION; PHENOTYPE; QUESTIONNAIRES; YOUNG ADULT;

EID: 61849088996     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1468     Document Type: Article

References (17)

1. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bot-tazzo GF, Holman R: UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes: UK Prospective Diabetes Study Group. Lancet 350:1288-1293, 1997
2. Carlsson S, Midthjell K, Tesfamarian MY, Grill V: Age, overweight and physical inactivity increase the risk of latent autoimmune diabetes in adults: results from the Nord-Tr0ndelag Health Study. Diabetolo-gia 50:55-58, 2007
3. Tuomi T, Carlsson A, Li H, Isomaa B, Mi-ettinen A, Nilsson A, Nissen M, Ehrn-strom BO, Forsen B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen MR, Groop LC: Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150-157, 1999
4. Genovese S, Bazzigaluppi E, Goncalves D, Ciucci A, Cavallo MG, Purrello F, Anello M, Rotella CM, Bardini G, Vaccaro O, Ric-cardi G, Travaglini P, Morenghi E, Bosi E, Pozzilli P: Clinical phenotype and (3-cell autoimmunity in Italian patients with adult-onset diabetes. Eur J Endocrinol 154: 441-447, 2006
5. Romkens TE, Kusters GC, Netea MG, Net-ten PM: Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital. NethJ Med 64:114-118, 2006
6. Isomaa B, Almgren P, Henricsson M, Taskinen MR, Tuomi T, Groop L, Sarelin L: Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care 22:1347-1353, 1999
7. Brophy S, Yderstraede K, Mauricio D, Hunter S, Hawa M, Pozzilli P, Schern-thaner G, Schloot N, Buzzetti R, Davies H, Leslie R, Williams DR, Action LADA Group: Time to insulin initiation can not be used in defining latent autoimmune diabetes in adults. Diabetes Care 31:439-441, 2008
8. Petersen JS, Hejnaes KR, Moody A, Karlsen AE, Marshall MO, Hoier-Madsen M, Boel E, Michelsen BK, Dyrberg T: Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 43:459-467, 1994
9. Buzzetti R, Di Pietro S, Giaccari A, Petrone A, Locatelli M, Suraci C, Capizzi M, Arpi ML, Bazzigaluppi E, Dotta F, Bosi E: High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Diabetes Care 30:932-938, 2007
10. Strebelow M, Schlosser M, Ziegler B, Rjas-anowski I, Ziegler M: Karlsburg type I diabetes risk study of a general population: frequencies and interactions of the four major type I diabetes-associated autoanti-bodies studied in 9419 schoolchildren. Diabetologia 42:661-670, 1999
11. Batstra MR, Petersen JS, Bruining GJ, Grobbee DE, de Man SA, Molenaar JL, Dyrberg T, Aanstoot HJ: Low prevalence of GAD and IA2 antibodies in schoolchildren from a village in the southwestern section of the Netherlands. Hum Immunol 62:1106-1110, 2001
12. Kulmala P, RahkoJ, Savola K, Vahasalo P, Sjoroos M, Reunanen A, Ilonen J, Knip M: Beta-cell autoimmunity, genetic susceptibility, and progression to type 1 diabetes in unaffected schoolchildren. Diabetes Care 24:171-173, 2001
13. Carlsson S, Midthjell K, Grill V: Influence of family history of diabetes on incidence and prevalence of latent autoimmune diabetes of the adult: results from the Nord-Tr0ndelag Health Study. Diabetes Care 30:3040-3045, 2007
14. Cervin C, Lyssenko V, Bakhtadze E, Lind-holm E, Nilsson P, Tuomi T, Cilio CM, Groop L: Genetic similarities between LADA, type 1 and type 2 diabetes. Diabetes 57:1433-1437, 2008
15. Castleden HA, Shields B, Bingley PJ, Williams AJ, Sampson M, Walker M, Gibson JM, McCarthy MI, Hitman GA, Levy JC, Hattersley AT, Vaidya B, Pearson ER: GAD antibodies in probands and their relatives in a cohort clinically selected for type 2 diabetes. Diabet Med 23:834-838, 2006
16. Clauson P, Linnarsson R, Gottsater A, Sundkvist G, Grill V: Relationships between diabetes duration, metabolic control and beta-cell function in a representative population of type 2 diabetic patients in Sweden. DiabetMed 11:794-801, 1994
17. Coordt MC, Ruhe RC, McDonald RB: Aging and insulin secretion. ProcSoc Exp Biol Med 209:213-222, 1995